Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients

Journal of Affective Disorders

Volumn 54, Issue 3, 1999, Pages 315-317

  Hardoy, Maria Carolina ^a   Hardoy, Maria Julieta ^b   Carta, Mauro Giovanni ^a   Cabras, Pier Luigi ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Psychiatric Unit   (Italy)

Author keywords

Affective disorder; Gabapentin; Movement disorders; Tardive dyskinesia

Indexed keywords

ANTIDEPRESSANT AGENT; BACLOFEN; BOTULINUM TOXIN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLOZAPINE; FLUOXETINE; GABAPENTIN; LITHIUM; NEUROLEPTIC AGENT; PAROXETINE; VALPROIC ACID;

ADULT; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOTOR DYSFUNCTION; PRIORITY JOURNAL; SCHIZOIDISM; SEDATION; TARDIVE DYSKINESIA;

ACETIC ACIDS; ADULT; AMINES; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DYSKINESIA, DRUG-INDUCED; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; TREATMENT OUTCOME;

EID: 0032792123     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00085-3     Document Type: Article

References (14)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, D.C.
2. Cabras P.L., Hardoy M.J., Hardoy M.C., Carta M.G. Clinical experiences with gabapentin in patients with bipolar and schizoaffective disorder: results of an open label study. J. Clin. Psychiatry. 60:(4):1999;245-248.
3. Casey D.E. Affective disorders and tardive dyskinesia. Encephale. 14:1988;221-226.
4. Chan P., de Marinis A., Barrientos N. Gabapentin and motor fluctuations in parkinson/Es disease. Movement disorders. 4:1997;608-623.
5. Chudnow R.S., Dewey R.B. Jr., Lawson C.R. Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients. Arch. Neurol. 54:1997;910-912.
6. Chudnow R.S., Mimbela R.A., Owen D.B., Roach E.S. Gabapentin for familial paroxysmal dystonic choreoathetosis. Neurology. 49:1997;1441-1442.
7. Gruenthal M., Mueller M., Olson W.L., Priebe M.M., Sherwood A.M., Olson W.H. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord. 35:1997;686-689.
8. Hardoy M.J., Hardoy M.C., Carta M.G., Cabras P.L. Gabapentin in bipolar disorder: does a specific effect on hostility exist? Psychiatric Networks. 1-2:1998;60-64.
9. Knoll J., Stegman K., Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J. Affect. Disord. 49:1998;229-233.
10. McElroy S.L., Soutullo C.A., Keck P.E. Jr., Kmetz G.F. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann. Clin. Psych. 9:1997;99-103.
11. Olson W.L., Gruenthal M., Mueller M.E., Olson W.H. Gabapentin for parkinsonism: a double-blind, placebD-controlled, crossover trial. Am. J. Med. 102:1997;60-66.
12. Reeves A.L., So E.L., Sharbrough F.W., Krahn L.E. Movements disorders associated with the use of gabapentin. Epilepsia. 37:1996;988-990.
13. Rosenbaum A.H., Niven R.G., Hanson H.P., et al. Tardive dyskinesia: relationship with primary affective disorder. Dis. Nerv. Syst. 38:1977;423-426.
14. Ryback R., Ryback L. Gabapentin for behavioral dyscontrol. Am. J. Psychiatry. 152:1995;1399.